Ezziddin S - Search Results

1

Detection efficacy of [⁸⁹Zr]Zr-PSMA-617 PET/CT in [⁶⁸Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer.

Rosar F, Khreish F, Marlowe RJ, Schaefer-Schuler A, Burgard C, Maus S, Petto S, Bartholomä M, Ezziddin S. Rosar F, et al. Among authors: ezziddin s. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2899-2909. doi: 10.1007/s00259-023-06241-0. Epub 2023 May 6. Eur J Nucl Med Mol Imaging. 2023. PMID: 37148297 Free PMC article.

2

[Therapy with radioisotopes in oncology. Palliative and curative approaches].

Biersack HJ, Ezziddin S, Risse J, Bender H, Palmedo H. Biersack HJ, et al. Among authors: ezziddin s. Schmerz. 2005 Feb;19(1):9-17. doi: 10.1007/s00482-003-0293-z. Schmerz. 2005. PMID: 15712003 Review. German.

3

Myeloid neoplasms after chemotherapy and PRRT: myth and reality.

Bodei L, Modlin IM, Luster M, Forrer F, Cremonesi M, Hicks RJ, Ezziddin S, Kidd M, Chiti A. Bodei L, et al. Among authors: ezziddin s. Endocr Relat Cancer. 2016 Aug;23(8):C1-7. doi: 10.1530/ERC-16-0258. Epub 2016 Jun 28. Endocr Relat Cancer. 2016. PMID: 27353035

4

Tc-99m labelled anti CD 66 antigranulocyte antibody imaging for assessment of bone marrow reserve.

Matthies A, Reinhardt M, Palmedo H, Ezziddin S, Abramowski B, Kuhn W, Biersack HJ, von Mallek D. Matthies A, et al. Among authors: ezziddin s. Cancer Invest. 2005;23(2):119-22. Cancer Invest. 2005. PMID: 15813503

5

Impact of thyroid metabolism on the course of INR levels in a patient with systemic anticoagulation suffering from amiodarone-induced thyrotoxicosis.

Bucerius J, Ezziddin S, Brockmann H, Palmedo H, Biersack HJ. Bucerius J, et al. Among authors: ezziddin s. Exp Clin Endocrinol Diabetes. 2007 Oct;115(9):606-9. doi: 10.1055/s-2007-984439. Exp Clin Endocrinol Diabetes. 2007. PMID: 17943696

6

Incremental diagnostic value of SPET/CT in precise localization of extraskeletal uptake of bone-seeking agents in multiple myeloma.

Gholamrezanezhad A, Sabet A, Ezziddin S, Biersack HJ, Ahmadzadehfar H. Gholamrezanezhad A, et al. Among authors: ezziddin s. Hell J Nucl Med. 2010 Sep-Dec;13(3):285-6. Hell J Nucl Med. 2010. PMID: 21193889 No abstract available.

7

Subclinical hyperthyroidism seems not to have a significant impact on systemic anticoagulation in patients with coumarin therapy.

Bucerius J, Naubereit A, Joe AY, Ezziddin S, Biermann K, Risse J, Palmedo H, Oldenburg J, Biersack HJ. Bucerius J, et al. Among authors: ezziddin s. Thromb Haemost. 2008 Nov;100(5):803-9. Thromb Haemost. 2008. PMID: 18989524

8

Somatostatin receptor scintigraphy in the follow-up of myasthenia gravis.

Gao ZR, Kornblum C, Flacke S, Logvinski T, Yüksel M, An R, Klockgether T, Biersack HJ, Ezziddin S. Gao ZR, et al. Among authors: ezziddin s. Neurol Sci. 2007 Aug;28(4):175-80. doi: 10.1007/s10072-007-0816-y. Epub 2007 Aug 10. Neurol Sci. 2007. PMID: 17690847

9

Peptide receptor radionuclide therapy for neuroendocrine tumors in Germany: first results of a multi-institutional cancer registry.

Hörsch D, Ezziddin S, Haug A, Gratz KF, Dunkelmann S, Krause BJ, Schümichen C, Bengel FM, Knapp WH, Bartenstein P, Biersack HJ, Plöckinger U, Schwartz-Fuchs S, Baum RP. Hörsch D, et al. Among authors: ezziddin s. Recent Results Cancer Res. 2013;194:457-65. doi: 10.1007/978-3-642-27994-2_25. Recent Results Cancer Res. 2013. PMID: 22918775

10

Unusual case of well-differentiated papillary thyroid carcinoma lacking thyroglobulin expression while still concentrating radioiodine.

Singh B, Bollmann R, Ahmadzadehfar H, Biersack HJ, Ezziddin S. Singh B, et al. Among authors: ezziddin s. Br J Radiol. 2006 Sep;79(945):e84-7. doi: 10.1259/bjr/62250180. Br J Radiol. 2006. PMID: 16940367

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

173 results

Search Page